12 Common problems in induction of ovulation

Bailliere's Clinical Obstetrics and Gynaecology

Volumn 4, Issue 3, 1990, Pages 609-625

  Hamilton Fairley, Diana ^a   Franks, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADOTROPIN;

ADULT; DRUG RESISTANCE; FEMALE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; REVIEW;

ANOVULATION; FEMALE; HUMAN; HYPOGONADISM; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME;

EID: 0025221184     PISSN: 09503552     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3552(05)80313-X     Document Type: Article

References (96)

1. Multifollicular ovaries: clinical and endocrine features and responses to pulsatile gonadotrophin releasing hormone
2. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
3. Fertility following bi-lateral ovarian wedge resection: a critical analysis of 90 consecutive cases of the polycystic ovary syndrome
4. Insulin-like growth factors as intra-ovarian regulators of granulosa cell growth and function
5. Premature ovarian failure
6. Premature ovarian failure: its relationship to autoimmune disease
7. Pregnancies after premature ovarian failure
8. Induction of fertility with pulsatile LHRH
9. A search for antibodies to luteinizing hormone receptors in premature ovarian failure
10. Pulsatile LRH administration to women with bromocriptine-resistant hyperprolactinaemia
11. Human gonadotrophin therapy
12. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotrophin in a panhypopituitary patient
13. Comparison between human menopausal gonadotrophin and purified FSH in the treatment of women with polycystic ovarian disease
14. Immaturity of the 24 hour luteinizing hormone secretory pattern in anorexia nervosa
15. Factors involved in the induction of fertile ovulation with human gonadotrophins
16. GnRH agonist administration in polycystic ovary syndrome
17. Post ovarian wedge resection adhesive disease
18. Oocyte donation and in vitro fertilization for hypergonadotrophic hypogonadism
19. Induction of ovulation in polycystic ovary syndrome with a combination of a luteinising hormone releasing analog and exogenous gonadotrophins
20. Pregnancy after oocyte cryopreservation
21. Induction of ovulation by pulsatile intravenous administration of LHRH in polycystic ovarian disease
22. Primary ovarian failure. Juvenile rheumatoid arthritis and vitiligo
23. Premature menopause 1, etiology
24. Incidence of premature ovarian failure
25. The use of LHRH analogues in ovulation induction and induction of multiple follicular growth for in vitro fertilisation
26. Growth hormone increases ovarian levels of immunoreactive somatomedin c/insulin-like growth factor-I in vitro
27. Ovulation induction with human menopausal gonadotrophins
28. Cumulative conception rates following gonadotrophin therapy
29. Five cases of Addison's disease with so called atrophy of adrenal cartels
30. Factors influencing the pregnancy and complication rates with human menopausal gonadotrophin therapy
31. The gonadotrophin resistant ovary syndrome: a curable disease
32. LHRH analogues for ovulation induction with particular reference to Polycystic Ovary Syndrome
33. Successful treatment of infertile women with oligomenorhoea using a combination of an LHRH agonist and exogenous gonadotrophins
34. Primary and secondary amenorrhoea
35. Polycystic ovary syndrome: a changing perspective
36. Ovulatory disorders in women with polycystic ovary syndrome
37. Use of LHRH agonists in the treatment of anovulation in women with polycystic ovary syndrome
38. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome
39. Treatment of female and male sterility with human gonadotrophins
40. Pregnancies following treatment with human gonadotrophins with special reference to the problem of multiple birth
41. Rate of follicular growth in the human ovary
42. Hypergonadotrophin amenorrhoea: aetiology and outcome in 93 young women
43. LHRH analogue therapy in infertile women with luteal phase defects
44. Synergism of pulsatile LHRH therapy with oral Clomiphene treatment
45. Growth hormone facilitates ovulation induction by gonadotrophins
46. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.
47. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation
48. Cotreatment with human growth hormone and gonadotrophins for induction of ovulation: a controlled clinical trial
49. Ovulation failure and induction
50. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies
51. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease
52. Gonadotrophin induced pregnancy following ‘premature ovarian failure’
53. The genetic aspects of primary eunuchoidism
54. Induction of ovulation with chronic intermittent (pulsatile) administration of LHRH in women with hypothalamic and hyperprolactinaemic amenorrhoea
55. Pregnancies following chronic intermittent (pulsatile) administration of GnRH by means of a portable pump (Zyclomat)—a new approach to the treatment of infertility in hypothalamic amenorrhoea
56. Polycystic ovarian syndrome: a retrospective study of the therapeutic effect of ovarian wedge resection after unsuccessful treatment with clomiphene citrate
57. Induction of ovulation: human gonadotrophins
58. The establishment and maintenance of pregnancy using in vitro fertilisation and embryo donation in a patient with primary ovarian failure
59. Induction of ovulation with pulsatile luteinizing hormone-releasing hormone
60. Reduced frequency of luteinizing hormone pulses in women with weight loss-related amenorrhoea and multifollicular ovaries
61. The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cell culture
62. Luteinizing hormone releasing hormone analogue in treatment of hypergonadotrophic amenorrhoea
63. Review of 59 patients with hypergonadotrophic hypogonadism
64. Influence de la ménopause précose, naturelle on chirurgicale sur le déclenchement des coronantes
65. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries
66. The pituitary responsiveness to acute and chronic administration of gonadotrophin releasing hormone in acute and recovery stages of anorexia nervosa
67. The study of induction of ovulation with menotropins: analysis of results of 1897 treatment cycles
68. The significance of FSH elevation in young women with disorders of ovulation
69. Outcome of in vitro fertilisation in women with low response to ovarian stimulation
70. Ovulation of a single dominant follicle stimulating hormone in women with polycystic ovary syndrome
71. Recovery of luteal function after interruption of gonadotrophin secretion in the mid-luteal phase of the menstrual cycle
72. Low-dose follicle-stimulating hormone in the treatment of polycystic ovary syndrome: a comparison of pulsatile subcutaneous with daily intramuscular therapy
73. Human menopausal gonadotrophins for anovulation and sterility
74. The Kallman syndrome: a clinical genetic and endocrine view of nine affected women
75. Premature ovarian failure
76. A prospective randomized comparative study of low dose HMG and FSH in polycystic ovary syndrome (PCOS)
77. The use of gonadotrophins for induction of ovulation
78. The use of human menopausal and chorionic gonadotrophin for induction of ovulation
79. Pregnancy following the insensitive ovary syndrome
80. Ovulation induction in polycystic ovary syndrome with urinary follicle stimulating hormone or human menopausal gonadotrophin
81. Use of human menopausal gonadotrophins for the induction of ovulation
82. Oestrogen treatment and subsequent pregnancy in two patients with severe hypergonadotrophic ovarian failure
83. Children of mothers with bulimia nervosa
84. The effect of gonadotrophin suppression on the induction of ovulation in premature ovarian failure patients
85. May wedge resection still be useful in patients with polycystic ovarian disease refractory to clomiphene citrate?
86. Return of fertility after 12 years of autoimmune ovarian failure
87. Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy
88. Treatment of anovulation with menotrophins
89. Premature ovarian failure
90. Pregnancy outcome in underweight women following spontaneous and induced ovulation
91. Ovarian failure and anti-ovarian antibodies in association with hypoparathyroidism, moniliasis and Addison's and Hashimoto's disease
92. The use of human gonadotrophins for the induction of ovulation in women with polycystic ovarian disease
93. Induction of ovulation with gonadotrophins a 10 year review
94. Partial gonadotrophin resistance in pseudohypoparathyroidism
95. Spontaneous pregnancy in a patient with hypergonadotrophic amenorrhoea
96. Pregnancies in primary amenorrhoea with normally developed secondary sexual characteristics